Upload
Featured Recent Articles Topics Login Upload

Search Results for 'death stroke'

death stroke published presentations and documents on DocSlides.

PPT 1b – study of disease
PPT 1b – study of disease
by ellena-manuel
Lesson objective – to learn how . disease is re...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
Trial Design Evolocumab SC
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
Transcarotid Artery Revascularization
Transcarotid Artery Revascularization
by karlyn-bohler
versus . Transfemoral Carotid Artery Stenting fo...
PPAR  activation Clinical
PPAR  activation Clinical
by maniakti
evidence. Evolution of clinical evidence supportin...
1 year results of the TOTAL trial:
1 year results of the TOTAL trial:
by pressio
Randomized trial of manual . Thrombectomy. in STE...
FOCUSSEMINARTHEBESTOFPOPULATIONRESEARCHSTUDIESJACCFOCUSSEMINARThrombol
FOCUSSEMINARTHEBESTOFPOPULATIONRESEARCHSTUDIESJACCFOCUSSEMINARThrombol
by hailey
In1984theNationalHeartLungandBloodInstituteNHLBIde...
DM and CVD Risk Prioritizing Elements of CVD Risk Management in Clinical Diabetes Practice
DM and CVD Risk Prioritizing Elements of CVD Risk Management in Clinical Diabetes Practice
by susan
Prof Kausik Ray, . BSc (. hons. ), . MBChB. , MRCP...
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
Placebo (n = 2,333) Empaglifozin
Placebo (n = 2,333) Empaglifozin
by SugarPlumFairy
(. n . = 4,687). EMPA-REG OUTCOME. Primary . outco...
Tbe Reltb Cce of Romeless Pecsons Pct SS Rpectbecmi nd Ret
Tbe Reltb Cce of Romeless Pecsons Pct SS Rpectbecmi nd Ret
by madeline
eat-related conditions occur when excess heat taxe...
Diabetes and Coronary Artery
Diabetes and Coronary Artery
by madison
Disease . By . . Jean . Molinary. , . DO. Screeni...
Two-year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-risk Randomized Trial
Two-year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-risk Randomized Trial
by braylen673
Low-risk Randomized Trial. Michael J. Mack, . MD &...